If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
47.80    0.30 (0.63%)
Bid:
47.45
Ask:
49.20
Spread: 1.75 (3.688%)
Market Cap: £190.30m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

28 Apr 2016 15:01

RNS Number : 7099W
CLS Holdings PLC
28 April 2016
 

 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CLS Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Creative Value Investment Group Limited ("CVIG")

4. Full name of shareholder(s) (if different from 3.):iv

Creative Value Investment I Limited

Creative Value Investment II Limited

Creative Value Investment III Limited

(together, the "CVIs")

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

28 April 2016

6. Date on which issuer notified:

28 April 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 50%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB0001592475

Nil

Nil

Nil

 

21,369,429

 

50.70%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

21,369,429

50.70%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

The following undertakings, which immediately following the transaction were each directly held and beneficially owned by CVIG, directly hold the following number of shares in the issuer:

 

Creative Value Investment I Limited: 8,153,810 (19.34%)

Creative Value Investment II Limited: 6,094,828 (14.46%)

Creative Value Investment III Limited: 7,120,791 (16.89%)

 

Total: 50.70%

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

Sten Mortstedt has transferred all of his shareholdings in the CVIs to CVIG in consideration for the issue of shares in CVIG to Sten Mortstedt. Immediately following that transaction, Sten Mortstedt settled his entire shareholding in CVIG into The Sten and Karin Mortstedt Family & Charity Trust. The beneficial interest of Sten Mortstedt in the issuer remains unchanged as a result of these transactions.

 

14. Contact name:

Peter Zonabend

15. Contact telephone number:

+41 81 252 55 47

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKFDKQBKDKQB
Date   Source Headline
16th May 20254:35 pmRNSResult of AGM
13th May 20254:03 pmRNSDirector/PDMR Shareholding
11th Apr 20254:09 pmRNSDirector/PDMR Shareholding
8th Apr 20253:43 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:48 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAnnual Financial Report
27th Mar 20257:00 amRNSSale of Spring Mews Student
19th Mar 20257:31 amRNSDirector Declaration
13th Mar 20255:02 pmRNSDirector/PDMR Shareholding
26th Feb 20255:53 pmRNSTrading Update Correction
24th Feb 20257:00 amRNSTrading Update 24 February 2025
11th Feb 20253:13 pmRNSDirector/PDMR Shareholding
6th Feb 20257:00 amRNSUpdated redevelopment plans for Spring Gardens
14th Jan 20255:26 pmRNSTransfer of Treasury Shares to EBT and TVR
10th Jan 20254:33 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSCLS leases 29,816 sf for 10 years at Fetter Lane
19th Dec 20247:00 amRNSCLS leases 9,600 sqm to the City of Dortmund
11th Dec 202412:46 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTrading Update 12 November 2024
12th Nov 20245:21 pmRNSDirector/PDMR Shareholding
11th Oct 20241:51 pmRNSDirector/PDMR Shareholding
11th Sep 20244:19 pmRNSDirector/PDMR Shareholding
6th Sep 20241:51 pmRNSChange of Auditor
4th Sep 20247:00 amRNSCLS leases over 8,900 sqm in Hamburg, Germany
12th Aug 20243:24 pmRNSDirector/PDMR Shareholding
7th Aug 20247:01 amRNSCLS Holdings Half Year Report
7th Aug 20247:00 amRNSCLS leases 12,052 sqft at Artesian, Prescot Street
1st Aug 20247:00 amRNSNotice of Half Year Results
11th Jul 202411:24 amRNSDirector/PDMR Shareholding
28th Jun 20244:58 pmRNSDirector Declaration
24th Jun 20247:00 amRNSCLS development plans for Citadel Place, Vauxhall
17th Jun 20247:00 amRNSCLS announces conversion of Debussy, Paris
14th Jun 20245:32 pmRNSDirector/PDMR Shareholding
10th Jun 20247:00 amRNSCLS updates on further sales progress
17th May 202412:52 pmRNSDirector Declaration
9th May 202411:18 amRNSDirector/PDMR Shareholding
9th May 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:33 pmRNSResult of AGM
15th Apr 20247:00 amRNSCLS Announces the Sale of Westminster Tower
11th Apr 20244:34 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSCLS Investor Presentation: Investor Meet Company
22nd Mar 20245:31 pmRNSAnnual Financial Report
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSAnnual Financial Report
28th Feb 202412:00 pmRNSNotice of Results
7th Feb 20245:37 pmRNSDirector/PDMR Shareholding
9th Jan 20245:27 pmRNSDirector/PDMR Shareholding
8th Dec 20235:40 pmRNSDirector/PDMR Shareholding
21st Nov 20234:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.